Future of breast screening at risk over payouts
BreastCheck’s national clinical director, Ann O’Doherty, said her biggest fear was that the litigation was going to be so costly that politicians would stop funding screening and put the resources into symptomatic breast cancer services.
Prof O’Doherty said she has worked in breast screening for 30 years and would not have more than one medico-legal case a year.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.



